A soluble factor secreted by an HIV-1-resistant cell line blocks transcription through inactivating the DNA-binding capacity of the NF-κB p65/p50 dimer

Journal of Immunology

Volumn 175, Issue 4, 2005, Pages 2548-2554

  Lesner, Adam ^a   Li, Yuchang ^a   Nitkiewicz, Jadwiga ^a   Li, Guanhua ^a   Kartvelishvili, Alex ^a   Kartvelishvili, Magdalena ^a   Simm, Malgorzata ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL PROTEIN; DNA; HIV 1 RESISTANCE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; PROTEIN P60; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA BINDING; DNA PROTEIN COMPLEX; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; T LYMPHOCYTE; TRANSCRIPTION REGULATION; VIRUS RESISTANCE;

EID: 23444442271     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.4.2548     Document Type: Article

References (50)

1. + T cells during primary immune responses. Proc. Natl. Acad. Sci. USA 100: 15006-15010.
2. + cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells. J. Gen. Virol. 77: 2953-2962.
3. + cells correlates with the clinical state of HIV-infected individuals. Proc. Natl. Acad. Sci. USA 93: 13125-13130.
4. + T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation. J. Virol. 76: 569-581.
5. + T-cell-mediated suppression of HIV type 1 on viral phenotypes and mediation of phenotype-dependent suppression by viral envelope gene and not by β-chemokines. AIDS Res. Hum. Retroviruses 16: 117-124.
6. + T lymphocytes from HIV-exposed-uninfected individuals. AIDS 16: 1003-1008.
7. + cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by /3-chemokines. J. Virol. 75: 8306-8316.
8. + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. USA 92: 2308-2312.
9. Pal, R., A. Garzino-Demo, P. D. Markham, J. Bums, M. Brown, R. C. Gallo, and A. L. DeVico. 1997. Inhibition of HIV-1 infection by the β-chemokine MDC. Science 278: 695-698.
10. Simm, M., L. S. Miller, H. G. Durkin, M. Allen, W. Chao, A. Lesner, M. J. Potash, and D. J. Volsky. 2002. Induction of secreted human immunodeficiency virus type 1 (HIV-1) resistance factors in CD4-positive T lymphocytes by attenuated HIV-1 infection. Virology 294: 1-12.
11. Zhang, L., W. Yu, T. He, J. Yu, R. E. Caffrey, E. A. Dalmasso, S. Fu, T. Pham, J. Mei, J. J. Ho, et al. 2002. Contribution of human α-defensin l, 2, and 3 to the anti-HTV-1 activity of CD8 antiviral factor. Science 298: 995-1000.
12. + T cell responses associated with control of viremia. Science 278: 1447-1450.
13. Leith, J. G., K. F. Copeland, P. J. McKay, D. Bienzle, C. D. Richards, and K. L. Rosenthal. 1999. T cell-derived suppressive activity: evidence of autocrine noncytolytic control of HIV type 1 transcription and replication. AIDS Res. Hum. Retroviruses 15: 1553-1561.
14. + T cells from an HIV-1-infected nonprogressor: evidence of a novel pathway of resistance mediated by a soluble factor(s) that acts after virus entry. J. Virol. 73: 7891-7898.
15. Simm, M., O. Pekarskaya, M. J. Potash, and D. J. Volsky. 2000. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors. AIDS Res. Hum. Retroviruses 16: 943-952.
16. Kartvelishvili, A., A. Lesner, M. Szponar, and M. Simm. 2004. Microarray analysis of differentially expressed genes in cells resistant to HIV-1. Immunol. Lett. 93: 79-86.
17. + T cells resistant to HIV-1. Biochemistry 43: 16203-16211.
18. Cullen, B. R. 1991. Regulation of human immunodeficiency virus replication. Annu. Rev. Microbiol. 45: 219-250.
19. Demarchi, F., P. D'Agaro, A. Falaschi, and M. Giacca. 1992. Probing protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1 by in vivo footprinting. J. Virol. 66: 2514-2518.
20. Gaynor, R. 1992. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6: 347-363.
21. Guy, B., B. Acres, M. P. Kieny, and J. P. Lecocq. 1990. DNA binding factors that bind to the negative regulatory element of the human immunodeficiency virus-1: regulation by nef. J. Acquired Immune Defic. Syndr. 3: 797-809.
22. Jones, K. A., J. T. Kadonaga, P. A. Luciw, and R. Tjian. 1986. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 232: 755-759.
23. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63: 717-743.
24. Kamine, J., B. Elangovan, T. Subramanian, D. Coleman, and G. Chinnadurai. 1996. Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology 216: 357-366.
25. Pereira, L. A., K. Bentley, A. Peeters, M. J. Churchill, and N. J. Deacon. 2000. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 28: 663-668.
26. Sune, C., and M. A. Garcia-Blanco. 1995. Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 69: 6572-6576.
27. Sune, C., and M. A. Garcia-Blanco. 1995. Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors. J. Virol. 69: 3098-3107.
28. White, M. R., M. Masuko, L. Amet, G. Elliott, M. Braddock, A. J. Kingsman, and S. M. Kingsman. 1995. Real-time analysis of the transcriptional regulation of HIV and hCMV promoters in single mammalian cells. J. Cell Sci. 108: 441-455.
29. Zhang, L., Y. Huang, H. Yuan, B. K. Chen, J. Ip, and D. D. Ho. 1997. Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 71: 5608-5613.
30. Simm, M., Z. Su, E. Y. Huang, Y. Chen, H. Jiang, D. J. Volsky, and P. B. Fisher. 2001. Cloning of differentially expressed genes in an HIV-1 resistant T cell clone by rapid subtraction hybridization, RaSH. Gene 269: 93-101.
31. Su, Z. Z., Y. Chen, D. C. Kang, W. Chao, M. Simm, D. J. Volsky, and P. B. Fisher. 2003. Customized rapid subtraction hybridization (RaSH) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-α treatment. Gene 306: 67-78.
32. Aguilar-Cordova, E., J. Chinen, L. Donehower, D. E. Lewis, and J. W. Belmont. 1994. A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res. Hum. Retroviruses 10: 295-301.
33. Connor, R. I., B. K. Chen, S. Choe, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206: 935-944.
34. Canki, M., J. N. Thai, W. Chao, A. Ghorpade, M. J. Potash, and D. J. Volsky. 2001. Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes. J. Virol. 75: 7925-7933.
35. Berkhout, B., and K. T. Jeang. 1992. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66: 139-149.
36. Swingler, S., A. Morris, and A. Easton. 1994. Tumour necrosis factor α and interleukin-1β induce specific subunits of NFKB to bind the HIV-1 enhancer: characterisation of transcription factors controlling human immunodeficiency virus type 1 gene expression in neural cells. Blochem. Blophys. Res. Commun. 203: 623-630.
37. + T lymphocytes. Science 256: 1452-1456.
38. Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, and T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382: 829-833.
39. + T cells. Science 270: 1811-1815.
40. + cells involves a noncytotoxic mechanism. J. Virol. 65: 5921-5927.
41. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179.
42. Saccani, S., S. Pantano, and G. Natoli. 2003. Modulation of NF-κB activity by exchange of dimers. Mol. Cell 11: 1563-1574.
43. Zabel, U., and P. A. Baeuerle. 1990. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 61: 255-265.
44. Chen-Park, F. E., D. B. Huang, B. Noro, D. Thanos, and G. Ghosh. 2002. The κB DNA sequence from the HIV long terminal repeat functions as an allosteric regulator of HIV transcription. J. Biol. Chem. 277: 24701-24708.
45. DeVico, A. L., and R. C. Gallo. 2004. Control of HIV-1 infection by soluble factors of the immune response. Nat. Rev. Microbiol. 2: 401-413.
46. Spencer, V. A., and J. R. Davie. 1999. Role of covalent modifications of histones in regulating gene expression. Gene 240: 1-12.
47. Ma, Z., R. C. Shah, M. J. Chang, and E. N. Benveniste. 2004. Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription. Mol. Cell. Biol. 24: 5496-5509.
48. Sheeny, A. M., N. C. Gaddis, J. D. Choi, and M. H. Malim. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650.
49. Towers, G., M. Bock, S. Martin, Y. Takeuchi, J. P. Stoye, and O. Danos. 2000. A conserved mechanism of retrovirus restriction in mammals. Proc. Natl. Acad. Sci. USA 97: 12295-12299.
50. Towers, G., M. Collins, and Y. Takeuchi. 2002. Abrogation of Ref1 retrovirus restriction in human cells. J. Virol. 76: 2548-2550.